Importance Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2
Omicron variant is critical to inform public health guidance. Objective To estimate the …

Importance A comprehensive understanding of the benefits of COVID-19 vaccination requires
consideration of disease attenuation, determined as whether people who develop COVID-…

Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease
since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the …

Background There are limited data on the effectiveness of the vaccines against symptomatic
coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect …

Objectives To characterize the clinical severity of covid-19 associated with the alpha, delta,
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …

Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. …

Background The prioritization of US health care personnel for early receipt of messenger
RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…

Background In South Africa, a 7-valent pneumococcal conjugate vaccine (PCV7) was
introduced in 2009 with a three-dose schedule for infants at 6, 14, and 36 weeks of age; a 13-…

Importance Efficacy of 2 doses of the BNT162b2 COVID-19 vaccine (Pfizer-BioNTech) against
COVID-19 was high in pediatric trials conducted before the SARS-CoV-2 Omicron variant …

Background: As SARS-CoV-2 vaccination coverage increases in the United States (US), there
is a need to understand the real-world effectiveness against severe Covid-19 and among …